Studies in ALS indicate that galectin-1 is expressed in neurofilamentous lesions [21], and no differences in plasma levels of galectin-1 and galectin-3 were found between patients with rapid progression and patients with slow progression [10]. The gene discussed is LGALS3; the disease is amyotrophic lateral sclerosis.